IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K306. A total of 81 filers reported holding IDERA PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 1.84 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $145,000 | -2.0% | 109,800 | +36.4% | 0.00% | – |
| Q1 2018 | $148,000 | +29.8% | 80,500 | +48.5% | 0.00% | – |
| Q4 2017 | $114,000 | -37.0% | 54,200 | -33.3% | 0.00% | – |
| Q3 2017 | $181,000 | +16.8% | 81,200 | -9.7% | 0.00% | – |
| Q2 2017 | $155,000 | -18.8% | 89,900 | +16.3% | 0.00% | – |
| Q1 2017 | $191,000 | +64.7% | 77,300 | 0.0% | 0.00% | – |
| Q4 2016 | $116,000 | -27.5% | 77,300 | +23.7% | 0.00% | – |
| Q3 2016 | $160,000 | +56.9% | 62,500 | -6.2% | 0.00% | – |
| Q2 2016 | $102,000 | -7.3% | 66,600 | +19.8% | 0.00% | – |
| Q1 2016 | $110,000 | -36.0% | 55,600 | 0.0% | 0.00% | – |
| Q4 2015 | $172,000 | -7.5% | 55,600 | 0.0% | 0.00% | – |
| Q3 2015 | $186,000 | -9.7% | 55,600 | 0.0% | 0.00% | – |
| Q2 2015 | $206,000 | +40.1% | 55,600 | +40.8% | 0.00% | – |
| Q1 2015 | $147,000 | +17.6% | 39,500 | +39.6% | 0.00% | – |
| Q4 2014 | $125,000 | +60.3% | 28,300 | -17.3% | 0.00% | – |
| Q3 2014 | $78,000 | -21.2% | 34,200 | 0.0% | 0.00% | – |
| Q2 2014 | $99,000 | +2375.0% | 34,200 | +3553.8% | 0.00% | – |
| Q1 2014 | $4,000 | 0.0% | 936 | 0.0% | 0.00% | – |
| Q4 2013 | $4,000 | +100.0% | 936 | 0.0% | 0.00% | – |
| Q3 2013 | $2,000 | – | 936 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|